Aptorum Group (Aptorum Group) Additional Paid-In Capital : $92.64 Mil(As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Aptorum Group Additional Paid-In Capital?

Aptorum Group's quarterly additional paid-in capital increased from Jun. 2022 ($44.34 Mil) to Dec. 2022 ($45.31 Mil) and increased from Dec. 2022 ($45.31 Mil) to Jun. 2023 ($92.64 Mil).

Aptorum Group's annual additional paid-in capital increased from Dec. 2020 ($38.25 Mil) to Dec. 2021 ($43.51 Mil) and increased from Dec. 2021 ($43.51 Mil) to Dec. 2022 ($45.31 Mil).

Aptorum Group Additional Paid-In Capital Historical Data

The historical data trend for Aptorum Group's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptorum Group Additional Paid-In Capital Chart

Aptorum Group Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Additional Paid-In Capital

Get a 7-Day Free Trial

23.00

24.89

38.25

43.51

45.31

Aptorum Group Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Additional Paid-In Capital	Get a 7-Day Free Trial							42.44	43.51	44.34	45.31	92.64

Aptorum Group Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Aptorum Group Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Aptorum Group's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptorum Group (Aptorum Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptorum Group Ltd (NAS:APM) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 Hanover Square, London, GBR, W1S 1BN

Website

https://www.aptorumgroup.com

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.